ABCA1 and colorectal carcinoma: Thus, the invasive capacities of DLD1_ABCA1 and Caco‐2_ABCA1 returned to normal levels after treatment with the BET inhibitor, indicating putative therapeutic effects of this drugs in CRC patients.